1-12 of 12
Wee Joo Chng, MB ChB, MRCP, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Management of Multiple Myeloma in Asia: Treatment Pattern and Cost

Shi Hui Clarice Choong, Adeline Lin, Teng Hiang Heng, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3159.
https://doi.org/10.1182/blood.V130.Suppl_1.3159.3159
Published: 2017
Journal Articles

MMSET I Acts As an Oncoprotein and Regulates GLO1 Expression in T(4;14) Multiple Myeloma Cells

Zhigang Xie, PhD, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, Bachelor, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 563.
https://doi.org/10.1182/blood.V130.Suppl_1.563.563
Published: 2017
Journal Articles

Plasma HCK Level As a Biomarker Predicting Poor Outcome in Acute Myeloid Leukemia

Pak Ling Lui, MBBS, Elaine Seah, BSc, Jianbiao Zhou, MD PhD, Baohong Lin, BSc, Wee Joo Chng, MB ChB, MRCP, PhD, Chin Hin Ng, MD MRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 3862.
https://doi.org/10.1182/blood.V130.Suppl_1.3862.3862
Published: 2017
Journal Articles

Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression

Nurulhuda Mustafa, PhD, Huey Fang Adina Nee, BSc, Xue Ting Jeannie Lee, BSc, Wei Jin, PhD, Yiling Yu, PhD, Yingnan Chen, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2814.
https://doi.org/10.1182/blood.V130.Suppl_1.2814.2814
Published: 2017
Journal Articles

Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

Cinnie Yentia Soekojo, MD MRCP, Guo-miao Wang, Yunxin Chen, Joshua Casan, Grace Wolyncewicz, Adeline Lin, LM Poon, Liang Piu Koh, Lip Kun Tan, Melissa Ooi, Yang Liu, Xiao-Jun Huang, MD, Andrew Spencer, MD, Sathish Kumar, Jin Lu, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3119.
https://doi.org/10.1182/blood.V130.Suppl_1.3119.3119
Published: 2017
Journal Articles

Quantitative Analysis of Multiplexed Immunofluorescence in T-Cell Lymphoma

Sanjay de Mel, BSc( Hons) BM (Hons) MRCP(UK) FRCPath, Shou- Nian Choo, Shuangyi Fan, Hoang Mai Phuong, Michal Hoppe, Wee Joo Chng, MB ChB, MRCP, PhD, Anand Jeyasekharan, Siok Bian Ng
Journal: Blood
Blood (2017) 130 (Supplement 1): 2800.
https://doi.org/10.1182/blood.V130.Suppl_1.2800.2800
Published: 2017
Journal Articles

Clinical Benefit of Depth of Response for Relapsed/Refractory Multiple Myeloma Patients Treated on Clinical Trials: Retrospective Analysis from Two Tertiary Centres

Hian Li Esther Chan, Dunnya De-Silva, Rakesh Popat, MD PhD, Neil Rabin, Ashu Wechalekar, Sufyan Achhala, Adeline Lin, Wee Joo Chng, MB ChB, MRCP, PhD, Kwee Yong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1825.
https://doi.org/10.1182/blood.V130.Suppl_1.1825.1825
Published: 2017
Journal Articles

JMJD3 Is a Potential Tumor Suppressor Gene That Cooperates with TP53 in Chromosome 17p13

Phaik Ju Teoh, PhD, Tae-Hoon Chung, Chirackal Sintosebastian, Rafael Fonseca, MD, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1761.
https://doi.org/10.1182/blood.V130.Suppl_1.1761.1761
Published: 2017
Journal Articles

A Descriptive Study of Viral RNA Sequences Identified from Single-Cell Analysis of Acute Myeloid Leukemia

Sharah Mae Capinpin, Chunkiat Lee, Ming Xuan Lin, Gabriel Yan, Dr, Kenneth Ban, Dr, Tin Wee Tan, Prof, Roger Foo, Assoc Prof, Wee Joo Chng, MB ChB, MRCP, PhD, Benedict Yan, Dr
Journal: Blood
Blood (2017) 130 (Supplement 1): 5091.
https://doi.org/10.1182/blood.V130.Suppl_1.5091.5091
Published: 2017
Journal Articles

Cytogenetic Abnormalities and Treatment with New Drugs on Clinical Trials Are Important Prognostic Markers for Myeloma in the Era of ISS and FISH Analysis

Cinnie Yentia Soekojo, Adeline Lin, Michelle Poon, Liang Piu Koh, Lip Kun Tan, Melissa G. Ooi, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2016) 128 (22): 4498.
https://doi.org/10.1182/blood.V128.22.4498.4498
Published: 2016
Journal Articles

Outcome and Prognostic Factors of Patients with Hematological Malignancies Admitted to an Intensive Care Unit

Pak Ling Lui, MBBS, MRCP, Rakshya Pandey, MBBS, MRCP, Jonathan Tian En Koh, Eng Soo Yap, MBBS, MRCP, Amartya Mukhopadhyay, MBBS, MRCP, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2016) 128 (22): 4796.
https://doi.org/10.1182/blood.V128.22.4796.4796
Published: 2016
Journal Articles

Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group

Sathish Kumar Gopalakrishnan, FRCPath, Shin-Yeu Ong, MD MRCP, MSE, Seok Jin Kim, Hae Su Kim, MD, Ji Yun Lee, Sung Hee Lim, Yunxin Chen, MBBS, MRCP, FRCPath, Sanjay De Mel, BSc, FRCPath, MRCP,, Melissa G. Ooi, Shilpa Surendran, MBBS, Adeline Lin, Daryl Tan, MBBS, MRCP, Brian G M Durie, Wee Joo Chng, MB ChB, MRCP, PhD, Kihyun Kim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4650.
https://doi.org/10.1182/blood.V128.22.4650.4650
Published: 2016